Signaling through IL-17C/IL-17RE Is Dispensable for Immunity to Systemic, Oral and Cutaneous Candidiasis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Conti, Heather R ^a   Whibley, Natasha ^a   Coleman, Bianca M ^a   Garg, Abhishek V ^a   Jaycox, Jillian R ^b   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 17RA; INTERLEUKIN 17RE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG; IL17C PROTEIN, MOUSE; INTERLEUKIN 17 RECEPTOR; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEFB3 GENE; FEMALE; FUNGAL LOAD; FUNGAL PHENOMENA AND FUNCTIONS; FUNGUS IMMUNITY; GENE; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; IL17C GENE; IMMUNITY; INFECTION SENSITIVITY; INVASIVE CANDIDIASIS; LCN2 GENE; MALE; MOUSE; NONHUMAN; OROPHARYNX CANDIDIASIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CANDIDIASIS; SURVIVAL; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; CANDIDIASIS; DEFICIENCY; DISEASE RESISTANCE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROTEIN SUBUNIT; THRUSH;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MUS;

ANIMALS; CANDIDIASIS; CANDIDIASIS, CUTANEOUS; CANDIDIASIS, ORAL; DISEASE RESISTANCE; FEMALE; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION;

EID: 84928901662     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122807     Document Type: Article

References (59)

1. Huppler AR, Bishu S, Gaffen SL. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res Ther. 2012; 14(4):217. doi: 10.1186/ar3893 PMID: 22838497
2. Glocker E, Grimbacher B. Chronic mucocutaneous candidiasis and congenital susceptibility to Candida. Curr Opin Allergy Clin Immunol. 2010; 10:542-50. doi: 10.1097/ACI.0b013e32833fd74f PMID: 20859203
3. Fidel PL Jr. Candida-Host Interactions in HIV Disease: Implications for Oropharyngeal Candidiasis. Adv Dent Res. 2011; 23(1):45-9. doi: 10.1177/0022034511399284 PMID: 21441480
4. Milner J, Holland S. The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol. 2013; 13:635-48. doi: 10.1038/nri3493 PMID: 23887241
5. Conti H, Peterson A, Huppler A, Brane L, Hernández-Santos N, Whibley N, et al. Oral-resident 'natural' Th17 cells and ãä-T cells control opportunistic Candida albicans infections. J Exp Med. 2014; 211 (10):2075-84. doi: 10.1084/jem.20130877 PMID: 25200028
6. Conti H, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann M, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009; 206(2):299-311. doi: 10.1084/jem.20081463 PMID: 19204111
7. Ferreira MC, Whibley N, Mamo AJ, Siebenlist U, Chan YR, Gaffen SL. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect Immun. 2014; 82(3):1030-5. doi: 10. 1128/IAI.01389-13 PMID: 24343647
8. Ho A, Shen F, Conti H, Patel N, Childs E, Peterson A, et al. IL-17RC is required for immune signaling via an extended SEFIR domain in the cytoplasmic tail J Immunol. 2010; 185:1063-70. doi: 10.4049/ jimmunol.0903739 PMID: 20554964
9. van de Veerdonk FL, Kullberg BJ, Verschueren IC, Hendriks T, van der Meer JW, Joosten LA, et al. Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock. 2010; 34(4):407-11. doi: 10.1097/SHK.0b013e3181d67041 PMID: 20160669
10. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004; 190(3):624-31. PMID: 15243941
11. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010; 185(9):5453-62. doi: 10.4049/jimmunol.1001153 PMID: 20921529
12. Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012; 366(13):1190-9.doi: 10.1056/NEJMoa1109997 PMID: 22455413
13. Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010; 2 (52):52ra72. doi: 10.1126/scitranslmed.3001107 PMID: 20926833
14. Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Annal Rheum Dis. 2013; 72 Suppl 2:116-23.
15. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, et al. Brodalumab, an anti-inter-leukin-17-receptor antibody for psoriasis. N Engl J Med. 2012; 366(13):1181-9. doi: 10.1056/ NEJMoa1109017 PMID: 22455412
16. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012; 11(10):763-76. doi: 10.1038/nrd3794 PMID: 23023676
17. Gaffen SL, Jain R, Garg A, Cua D. IL-23-IL-17 immune axis: Discovery, mechanistic understanding and clinical therapy. Nat Rev Immunol. 2014; 14(9):585-600. doi: 10.1038/nri3707 PMID: 25145755
18. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011; 34:149-62. doi: 10.1016/j.immuni.2011.02.012 PMID: 21349428
19. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, et al. Cutting Edge: Interleukin-17 signals through a heteromeric receptor complex. J Immunol. 2006; 177(1):36-9. PMID: 16785495
20. Kuestner R, Taft D, Haran A, Brandt C, Brender T, Lum K, et al. Identification of the IL-17 receptor related molecule, IL-17RC, as the receptor for IL-17F. J Immunol. 2007; 179:5462-73. PMID: 17911633
21. Song X, Zhu S, Shi P, Liu Y, Shi Y, Levin SD, et al. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nature Immunol. 2011; 12(12):1151-8.doi: 10.1038/ni.2155 PMID: 21993849
22. Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S, Lesch J, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nature Immunol. 2011; 12(12):1159-66. doi: 10.1038/ni.2156 PMID: 21993848
23. Golden JB, McCormick TS, Ward NL. IL-17 in psoriasis: implications for therapy and cardiovascular comorbidities. Cytokine. 2013; 62(2):195-201. doi: 10.1016/j.cyto.2013.03.013 PMID: 23562549
24. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, et al. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol. 2007; 179(10):7128-36. PMID: 17982105
25. Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A. 2000; 97(2):773-8.PMID: 10639155
26. Chang SH, Reynolds JM, Pappu BP, Chen G, Martinez GJ, Dong C. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 2011; 35(4):611-21.doi: 10.1016/j.immuni.2011.09.010 PMID: 21982598
27. Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S. IL-36ã Sustains a Proinflammatory Selfamplifying Loop with IL-17C in Anti-TNF-induced Psoriasiform Skin Lesions of Patients with Crohn's Disease. Inflamm Bowel Dis. 2014; 20(11)1891-901. doi: 10.1097/MIB.0000000000000198 PMID: 25299544
28. Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, Krueger JG, et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Derm. 2013; 133(1):17-26. doi: 10.1038/jid.2012.194 PMID: 22673731
29. Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, et al. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation. J Immunol. 2013; 190(5):2252-62. doi: 10. 4049/jimmunol.1201505 PMID: 23359500
30. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 2008; 14(3):282-9. doi: 10. 1038/nm1720 PMID: 18264109
31. Conti HR, Huppler AR, Whibley N, Gaffen SL. Animal models for candidiasis. Current protocols in immunology / edited by John E Coligan [et al]. 2014; 105:19 61-67.
32. Kamai Y, Kubota M, Kamai Y, Hosokawa T, Fukuoka T, Filler S. New model of oropharyngeal candidiasis in mice. Anti-microb Agents Chemo. 2001; 45:3195-7.
33. Whibley N, Maccallum DM, Vickers MA, Zafreen S, Waldmann H, Hori S, et al. Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol. 2014; 44(4):1069-83. doi: 10.1002/eji.201343604 PMID: 24435677
34. Solis NV, Filler SG. Mouse model of oropharyngeal candidiasis. Nat Protoc. 2012; 7(4):637-42. doi: 10. 1038/nprot.2012.011 PMID: 22402633
35. Hernández-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL. Th17 cells confer long term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013; 6:900-10. doi: 10.1038/mi.2012.128 PMID: 23250275
36. Huppler AR, Conti HR, Hernandez-Santos N, Biswas PS, Darville T, Gaffen SL. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J Immunol. 2014; 192:1745-52. doi: 10.4049/ jimmunol.1302265 PMID: 24442441
37. Hernández-Santos N, Gaffen SL. Th17 cells in immunity to Candida albicans. Cell Host Microbe. 2012; 11:425-35. doi: 10.1016/j.chom.2012.04.008 PMID: 22607796
38. Onishi R, Gaffen SL. IL-17 and its Target Genes: Mechanisms of IL-17 Function in Disease. Immunology. 2010; 129:311-21. doi: 10.1111/j.1365-2567.2009.03240.x PMID: 20409152
39. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. β-Defensins: Linking innate immunity and adaptive immunity through dendritic and T cell CCR6. Science. 1999; 286:525-8. PMID: 10521347
40. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, et al. Dectin-2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity. 2010; 32(5):681-91. doi: 10.1016/j.immuni.2010.05.001 PMID: 20493731
41. Ho A, Gaffen SL. IL-17RC: A partner in IL-17 signaling and beyond. Semin Immunopathol. 2010; 32 (1):33-42. doi: 10.1007/s00281-009-0185-0 PMID: 20012905
42. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cellmediated tissue damage. Nature Med. 2007; 13(2):139-45. PMID: 17290272
43. Puel A, Cypowji S, Bustamante J, Wright J, Liu L, Lim H, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011; 332:65-8. doi: 10.1126/science.1200439 PMID: 21350122
44. Gladiator A, Wangler N, Trautwein-Weidner K, Leibundgut-Landmann S. Cutting Edge: IL-17-Secreting Innate Lymphoid Cells Are Essential for Host Defense against Fungal Infection. J Immunol. 2013; 190:521-5. doi: 10.4049/jimmunol.1202924 PMID: 23255360
45. Johansen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K. Characterization of the in-terleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009; 160(2):319-24. doi: 10.1111/j.1365-2133.2008.08902.x PMID: 19016708
46. Reynolds JM, Martinez GJ, Nallaparaju KC, Chang SH, Wang YH, Dong C. Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J Immunol. 2012; 189(9):4226-30. doi: 10.4049/ jimmunol.1103014 PMID: 23024280
47. Yano J, Noverr MC, Fidel PL Jr. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins. Cytokine. 2012; 58(1):118-28. doi: 10.1016/j.cyto. 2011.11.021 PMID: 22182685
48. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One. 2011; 6(7):e22770. doi: 10.1371/journal.pone.0022770PMID: 21818387
49. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010; 10(7):479-89. doi: 10.1038/nri2800 PMID: 20559326
50. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. doi: 10.1038/nri3365 PMID: 23348417
51. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature Immunol. 2007; 8:639-46. PMID: 17486092
52. Bär E, Gladiator A, Bastidas S, Roschitzki B, Acha-Orbea H, Oxenius A, et al. A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J Immunol. 2012; 188(11):5636-43. doi: 10.4049/jimmunol.1200594 PMID: 22529294
53. Bishu S, Hernandez-Santos N, Simpson-Abelson M, Huppler AR, Conti HR, Ghilardi N, et al. CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect Immun. 2014; 82:1173-80. doi: 10.1128/IAI.01335-13 PMID: 24379290
54. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nature Immunol. 2011; 12(3):255-63.
55. Igyarto BZ, Haley K, Ortner D, Bobr A, Gerami-Nejad M, Edelson BT, et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity. 2011; 35(2):260-72. doi: 10.1016/j.immuni.2011.06.005 PMID: 21782478
56. Shen F, Hu Z, Goswami J, Gaffen SL. Identification of common transcriptional regulatory elements in in-terleukin-17 target genes. J Biol Chem. 2006; 281:24138-48. PMID: 16798734
57. Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, et al. A biallelic ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013; 39:676-86. doi: 10.1016/j.immuni.2013.09.002 PMID: 24120361
58. Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010; 207(2):299-308. doi: 10.1084/jem.20091669 PMID: 20123959
59. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010; 207(2):291-7. doi: 10.1084/jem.20091983 PMID: 20123958